Evidence map›Paper›PMID 40665497›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2025

Neonatal Outcomes Among Neonates of Women With and Without Type 1 Diabetes in Sweden From 2010 to 2022.

Alexandra Goldberg, Eva Wiberg-Itzel, Joanna Tingström, Cecilia Ekéus

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra GoldbergDepartment of Clinical Science and Education, Karolinska Institutet Soder Hospital, Stockholm, Sweden.ORCID 0000-0002-1282-1637
Eva Wiberg-ItzelDepartment of Clinical Science and Education, Karolinska Institutet Soder Hospital, Stockholm, Sweden.
Joanna TingströmDepartment of Clinical Science and Education, Karolinska Institutet Soder Hospital, Stockholm, Sweden.
Cecilia EkéusDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis register-based study aimed to investigate differences in adverse neonatal outcomes between neonates born to mothers with and without type 1 diabetes in Sweden.

methodsA nationwide cohort study was conducted using the Swedish Medical Birth Register, including all singleton births from 22 gestational weeks between 2010 and 2022. The neonatal outcomes among neonates of women with and without type 1 diabetes were studied with descriptive statistics and logistic regressions. Adjusted odds ratios (aORs) with 95% confidence intervals are presented.

resultsThe study consisted of 1 402 394 neonates, and 0.5% had a mother with type 1 diabetes. Neonates of mothers with type 1 diabetes had increased odds of stillbirth (aOR 2.54; 95% CI 1.98-3.28), congenital malformations (aOR 1.66; 95% CI 1.50-1.84), preterm birth (aOR 3.80; 95% CI 3.41-4.23), large for gestational age (aOR 22.0; 95% CI 20.9-23.1), hypoglycaemia (aOR 45.85; 95% CI 43.60-48.22), and neonatal death (aOR 4.1; 95% CI 3.00-5.83).

conclusionNeonates of mothers with type 1 diabetes continue to experience poorer neonatal outcomes, highlighting the need for more research on the causes and how care can be improved for their mothers during pregnancy.

Indexed as

Diabetes Mellitus, Type 1Pregnancy in DiabeticsPregnancy OutcomeAdultCohort StudiesFemaleHumansInfant, NewbornMalePregnancyRegistriesSwedenadverse neonatal outcomecongenital malformationslarge for gestational agematernal hyperglycemianeonatal hypoglycemiapretermregister studystillbirthtype 1 diabetes

Identifiers

PMID40665497
PMCPMC12599607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.